Thursday, December 9, 2010

S&S Food Inc. Issues An Alert On Uneviscerated Fish

Thursday, December 9, 2010 0

Recall -- Firm Press Release


FDA posts press releases and other notices of recalls and market withdrawals from the firms involved as a service to consumers, the media, and other interested parties. FDA does not endorse either the product or the company.

S&S Food Inc. Issues An Alert On Uneviscerated Fish



Contact:
Yan Shvartz
(718)677-6888


FOR IMMEDIATE RELEASE - December 6, 2010 - S&S Food Inc. at 1560 Troy Avenue, Brooklyn, NY 11203 is recalling DRIED FISH VOBLA GUTTED discovered by New York State Department of Agriculture and Markets Food Inspectors during a routine inspection and subsequent analysis of product by Food Laboratory personnel confirming that the fish was not properly eviscerated prior to processing.

This product may be contaminated with Clostridium botulinum spores, which can cause Botulism, a serious and potentially fatal food borne illness. Symptoms of botulism include blurred vision, general weakness and poor reflexes, difficulty in swallowing and respiratory paralysis.

The sale of un-eviscerated fish is prohibited under New York State Agriculture and Markets regulations because Clostridium botulinum spores are more likely to be concentrated in the viscera than any other portion of the fish. Un-eviscerated fish has been linked to outbreaks of botulism poisoning.

The recalled dried fish Vobla gutted comes in a coded, plastic vacuum packed bag with the following code: Production date: 21.06.2010, lot # 280610140 and is a product of Germany. This product was sold nationwide.

No illnesses have been reported to date in connection with this problem. Consumers who have DRIED FISH VOBLA GUTTED are advised not to eat it and should return it to the place of purchase. Consumer with questions may contact the company at (718) 677-6888.

###


Photo: Product Labels11
Recalled Product Photos Are Also Available on FDA's Flickr Photostream.


Original Source of content (press release) http://www.fda.gov/Safety/Recalls/ucm236087.htm

Pablo’s Produce, Inc. Recalls One Lot of Cilantro because of Possible Health Risk

Recall -- Firm Press Release


FDA posts press releases and other notices of recalls and market withdrawals from the firms involved as a service to consumers, the media, and other interested parties. FDA does not endorse either the product or the company.

Pablo’s Produce, Inc. Recalls One Lot of Cilantro because of Possible Health Risk


Contact:
Jessica Cueto
pablosproduce@yahoo.com
(805)797-3731

For Immediate Release - December 7, 2010 - Pablo’s Produce, Inc. of Oxnard, Ca is voluntarily recalling one lot of cilantro because it has the potential to be contaminated with Salmonella. The company is working with Health officials to inform consumers of this recall, and no illnesses have been reported to date.

Salmonella is an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. Healthy persons infected with salmonella often experience fever, diarrhea (which may be bloody), nausea, vomiting and abdominal pain. In rare circumstances, infection with salmonella can results in the organism getting into the bloodstream and producing more severe illnesses such as arterial infections (i.e., infected aneurysms), endocarditis and arthritis.

The recalled Cilantro was bundled with white twist ties with black lettering spelling the word “Cilantro” and  UPC # 03383801049. The twist tie also has the words “Pablo’s Produce of USA” in red and green writing. The cilantro was available for sale from November 24, 2010 through December 2, 2010.

The recall involves only one lot of cilantro and does not involve any other cilantro sold before or after the dates listed above or any other products distributed by Pablo’s Produce. This contamination was detected in a routine surveillance sample at a produce distributor in California. Consumers who are uncertain if they have any of the recalled cilantro, are urged to discard or return it to the place of purchase for a full refund.

Pablo’s Produce, Inc. continues to strive to keep food safety at the foremost priority.
Our commitment is the same today as it was 38 years ago, to provide quality products to our customers.

If you have any questions or concerns please contact Jessica Cueto at (805) 797-3731, Monday-Friday, 9am-4pm, or email pablosproduce@yahoo.com.

####
Photo: Product Labels


Original Source of FDA Press Release:  http://www.fda.gov/Safety/Recalls/ucm236232.htm

FDA issues guidance on public comment procedures at advisory committee meetings

FDA NEWS RELEASE

Press Release


For Immediate Release: Dec. 9, 2010
Media Inquiries: Pat El-Hinnawy, 301-796-4763, patricia.el-hinnawy@fda.hhs.gov
Consumer Inquiries: 888-INFO-FDA

FDA issues guidance on public comment procedures at advisory committee meetings

The U.S. Food and Drug Administration today issued final guidance for people who wish to comment during the agency’s advisory committee meetings. The guidance provides instructions on how to request a time to speak and how FDA staff should respond to requests to speak at the meetings.

The FDA encourages participation from all stakeholders in its decision-making process. Every advisory committee meeting includes an open public hearing session, during which interested people may present relevant information or their oral and/or written views.

The guidance finalizes information contained in the 2005 draft guidance titled The Open Public Hearing – FDA Advisory Committee Meetings – Draft Guidance.

Highlights of the guidance include:

• Before an advisory committee meeting, people may ask, either orally or in writing, to speak at the meeting; they should include contact information, topic to discuss, time requested; FDA usually allots 5-10 minutes per person.

• FDA staff responds to requests and, if the topic is unrelated to the committee’s work, may decline the request.

• At the meeting, speakers should identify themselves to FDA staff and provide any handouts or other materials, which staff then provides to committee members. These materials then become part of the meeting’s permanent record.

• Committee members are encouraged to ask questions of the speakers, to discover more information that might be useful to the committee’s deliberations. Committee members and the public should be reminded of the importance of the open public hearing session and that all speakers should be treated with courtesy and respect.

• Public speakers are encouraged to disclose any financial relationships they may have with the topic of the meeting or with sponsors of competitors of the products under discussion.

• FDA will provide a designated seating area for speakers.

Since meetings typically take several months to plan, we are implementing the new guidance starting with meetings held in March 2011.

Advisory committees enhance the FDA’s ability to protect and promote public health by ensuring FDA has access to comments from the public through the public hearing process provided in existing laws and regulations.

Each advisory committee meeting includes a comment period during which members of the public; individuals or spokespersons from the regulated industry (except the sponsor whose product is under review); consumer advocacy groups; and professional organizations, societies, or organizations are invited to speak.
###
For more information:

Guidance for the Public, FDA Advisory Committee Members, and FDA Staff: The Open Public Hearing at FDA Advisory Committee Meetings

http://www.fda.gov/downloads/RegulatoryInformation/Guidances/UCM236144.pdf

The Open Public Hearing – FDA Advisory Committee Meetings – Draft Guidance (2005)
http://www.fda.gov/RegulatoryInformation/Guidances/ucm125645.htm

FDA 101: Advisory Committees
http://www.fda.gov/ForConsumers/ConsumerUpdates/ucm048040.htm



Visit the FDA on Facebook

RSS Feed for FDA News Releases [what is RSS?]


Original Source: Content=http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm236245.htm
 
◄Design by Pocket Distributed by Deluxe Templates